Mangoceuticals (NASDAQ:MGRX) Issues Quarterly Earnings Results

Mangoceuticals (NASDAQ:MGRX) released its earnings results on Thursday. The company reported ($1.01) earnings per share for the quarter, Zacks reports. Mangoceuticals had a negative net margin of 1,237.00% and a negative return on equity of 138.00%.

Mangoceuticals Trading Up 1.9 %

Shares of NASDAQ:MGRX traded up $0.08 during mid-day trading on Thursday, reaching $4.35. The stock had a trading volume of 65,411 shares, compared to its average volume of 225,913. The firm has a 50 day simple moving average of $3.75 and a two-hundred day simple moving average of $14.74. Mangoceuticals has a twelve month low of $2.07 and a twelve month high of $16.80. The firm has a market cap of $10.82 million, a PE ratio of -0.75 and a beta of 1.51.

About Mangoceuticals

Mangoceuticals, Inc develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com.